Enliven Therapeutics Reports Promising Outcomes in Phase 1 Trial of ELVN-001 for Chronic Myeloid Leukemia
Sep 29, 2024
Clinical Investment Portfolios
Psyence Biomed Advances Toward Significant Clinical Milestones
Sep 16, 2024
Psyence Biomed Advances in Mental Health Therapies with Acquisition of Clairvoyant
Sep 6, 2024
India Poised for Dengue Vaccine by 2026 as Takeda Commences Trials
Jul 25, 2024
MiNK Therapeutics Announces Clinical Activity of AgenT-797 in Transplant Patient with ARDS
May 22, 2024
Aquestive Therapeutics Announces 2023 Financial Outcomes and Updates on Business Progress
Mar 6, 2024
Molecular Partners Announces Key Pipeline Updates at J.P. Morgan Healthcare Conference
Jan 8, 2024
Syros Pharmaceuticals Shares Climb on Promising Tamibarotene Study Results
Dec 8, 2023
Enveric Biosciences Reveals Decline in Revenue for Q3 2023 Amid Advancements of Psychedelics into Clinical Trials
Nov 15, 2023
Enveric Biosciences Reports Decline in Q3 Revenue as Psychedelic Therapeutics Progress
Nov 15, 2023